APA

Roca-Alonso L., Castellano L., Mills A., Dabrowska A. F., Sikkel M. B., Pellegrino L., Jacob J., Frampton A. E., Krell J., Coombes R. C., Harding S. E., Lyon A. R. & Stebbing J. (20160223). Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis. : Cell death & disease.

Chicago

Roca-Alonso L, Castellano L, Mills A, Dabrowska A F, Sikkel M B, Pellegrino L, Jacob J, Frampton A E, Krell J, Coombes R C, Harding S E, Lyon A R and Stebbing J. 20160223. Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis. : Cell death & disease.

Harvard

Roca-Alonso L., Castellano L., Mills A., Dabrowska A. F., Sikkel M. B., Pellegrino L., Jacob J., Frampton A. E., Krell J., Coombes R. C., Harding S. E., Lyon A. R. and Stebbing J. (20160223). Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis. : Cell death & disease.

MLA

Roca-Alonso L, Castellano L, Mills A, Dabrowska A F, Sikkel M B, Pellegrino L, Jacob J, Frampton A E, Krell J, Coombes R C, Harding S E, Lyon A R and Stebbing J. Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis. : Cell death & disease. 20160223.